Company Filing History:
Years Active: 2021
Title: Innovator Spotlight: Alexia De Gasperis and Her Hemostatic Flowable Invention
Introduction
Alexia De Gasperis, located in Saint Genis Laval, France, is an innovative inventor known for her contribution to medical advancements. With a focus on hemostatic solutions, her efforts have culminated in a significant patent that showcases her dedication to improving patient care.
Latest Patents
Alexia holds a patent for her invention titled "Hemostatic Flowable." This invention pertains to a kit designed for preparing a hemostatic flowable solution. The kit includes a hemostatic powder, which is composed of non-cross-linked fibrillar collagen containing at least 70% fibrous collagen by weight, along with at least one monosaccharide and one glycosaminoglycan. It also includes a saline solution that is mixed with the hemostatic powder to create the flowable formulation. The preparation involves several steps, including hydration of the hemostatic powder by mixing it with the saline solution.
Career Highlights
Alexia is associated with Biom'up France Sas, where she has played a pivotal role in developing innovative healthcare products. Her work focuses on creating effective medical solutions that enhance surgical outcomes and improve patient recovery times. The patent for the Hemostatic Flowable exemplifies her commitment to advancing medical technology.
Collaborations
Throughout her career, Alexia has collaborated with esteemed professionals such as William Spotnitz and Valérie Centis. These partnerships contribute to a rich exchange of ideas and expertise that drive innovation within the medical field.
Conclusion
In conclusion, Alexia De Gasperis stands out as an influential figure in the realm of medical innovation. Her patented hemostatic flowable kit represents a meaningful advancement in the management of bleeding during surgical procedures, highlighting her contributions to the healthcare industry. As she continues her work at Biom'up France Sas, her future innovations are anticipated to further enhance patient care and surgical techniques.